Richard Klausner
Richard D. Klausner is an American scientist who
served as the 11th director of the National Cancer Richard Klausner
Institute of the United States.
Early life and education
Klausner was born in 1950 or 1951.[1] His father was a
chemist, and Klausner would visit his father's
laboratory as a child. He began studying physics at
Yale University, but changed his focus to biology, with
the plan of becoming a doctor in a rural area.[1]
Klausner received his MD from Duke Medical School
in 1976.[2]
Career
11th Director of the National Cancer
In 1979, Klausner joined the National Institutes of Institute
Health (NIH) as a postdoctoral fellow. At age 30,
In office
Klausner was appointed to the chief of the cell biology
August 1, 1995 – September 30, 2001
and metabolism branch of the National Institute of
Child Health and Human Development.[1] President Bill Clinton
George W. Bush
In 1992, he directed the review of the NIH's intramural Preceded by Samuel Broder
research programs, in which he recommended Succeeded by Andrew C. von Eschenbach
sweeping changes.[1] He served as the director of the
Personal details
National Cancer Institute from 1995 to 2001, where he
managed a staff of 5,000 employees and a budget of Children 4
$4.5 billion.[3] In total, he spent more than 20 years at Alma mater Yale University
the NIH.[4]
Duke Medical School
He left the NCI to become the founding director of the Scientific career
Case Institute of Health, Science and Technology of Institutions National Institutes of Health
the Case Foundation.[4][5]
Case Foundation
He was the managing partner of the biotech venture Bill & Melinda Gates
capital firm, the Column Group.[6] From 2002 to 2005, Foundation
he was the executive director of the Bill & Melinda Juno Therapeutics
Gates Foundation.[3][7] GRAIL
Illumina
He was a member of the Searle Scholars advisory Altos Labs, Inc.
board.[8] He was a scientific advisor at the Fred
Hutchinson Cancer Research Center.[9] He has been an
Advisor to the Presidents of the Academies for counter-terrorism and a liaison to the White House Office
of Science & Technology Policy,[6] and was the chief strategy advisor for USAID.[10]
Klausner co-founded Juno Therapeutics in 2013, GRAIL (https://grail.com/) in 2015.[11][12] and
MindStrong Health in 2014. He was the chief medical officer of Illumina from 2013 to 2016.[13]
In 2022, Klausner co-founded Altos Labs and is currently Chief Scientist and Board Co-Chairman of the
company.[14]
He was president of the American Society for Clinical Investigation from 1995 to 1996.[12]
Research
His research focused on T cells and the potential for CAR-T therapies.[15] He also has published research
on the genetics of Von Hippel–Lindau disease, a condition which predisposes a person to developing
cancer.[9] He is an author of more than 300 scientific articles.[6]
Personal life
Klausner has two sons and twin daughters.[1]
Awards
1986 Elected to the American Society for Clinical Investigation (ASCI)[16]
1993 Elected to the National Academy of Sciences[17]
1995 Elected to the American Academy of Arts and Sciences[12]
1997 Dickson Prize in Medicine, University of Pittsburgh[12]
1998 Raymond Bourgine Award for Excellence in Cancer Research and Gold Medal of
Paris[12]
1999 ASCI Stanley J. Korsmeyer Award[16]
2000 Medal of Honour, International Agency for Research on Cancer[11]
2018 Elected fellow of the American Association for Cancer Research[12]
References
1. Kolata, Gina (12 December 1995). "SCIENTIST AT WORK: Richard Klausner;New
Administrator Is 'Not an Administrator' " (https://www.nytimes.com/1995/12/12/science/scient
ist-at-work-richard-klausner-new-administrator-is-not-an-administrator.html). The New York
Times. Retrieved 6 May 2019.
2. Ltd, BMJ Publishing Group (1 November 2001). "Richard Klausner Steps Down as NCI
Director" (https://jim.bmj.com/content/49/6/469.1). Journal of Investigative Medicine. 49 (6):
469. doi:10.2310/6650.2001.33610 (https://doi.org/10.2310%2F6650.2001.33610).
ISSN 1081-5589 (https://search.worldcat.org/issn/1081-5589). S2CID 219542301 (https://ap
i.semanticscholar.org/CorpusID:219542301). Retrieved 6 May 2019.
3. "Dr. Richard D. Klausner Named Executive Director of Global Health for Bill & Melinda
Gates Foundation" (https://www.gatesfoundation.org/Media-Center/Press-Releases/2002/0
5/Dr-Richard-D-Klausner-Executive-Director-of-Global-Health). Bill & Melinda Gates
Foundation. Retrieved 6 May 2019.
4. "NCI Director Richard Klausner Will Leave NIH - National Cancer Institute" (https://web.archi
ve.org/web/20120801052409/http://www.cancer.gov/newscenter/pressreleases/2001/klausn
erleave). 1 August 2012. Archived from the original (https://www.cancer.gov/newscenter/pre
ssreleases/2001/klausnerleave) on 2012-08-01. Retrieved 6 May 2019.
5. "NIH Record-10/02/2001--Klausner Leaves NIH to Head New Institute" (https://nihrecord.ni
h.gov/newsletters/10_02_2001/story10.htm). nihrecord.nih.gov. Retrieved 6 May 2019.
6. "Richard Klausner – Juno Therapeutics" (https://www.junotherapeutics.com/about-us/our-pe
ople/richard-klausner/). www.junotherapeutics.com. Retrieved 6 May 2019.
7. Paulson, Tom; Reporter, Seattle Post-Intelligencer (13 September 2005). "Gates
Foundation's global health chief leaving" (https://www.seattlepi.com/local/article/Gates-Foun
dation-s-global-health-chief-leaving-1182833.php). seattlepi.com. Retrieved 6 May 2019.
8. "Searle Scholars Program : Richard D. Klausner (Advisory Board)" (https://www.searleschol
ars.net/person/486). www.searlescholars.net. Retrieved 6 May 2019.
9. "Richard Klausner, ex-NCI head, joins center as senior adviser" (https://www.fredhutch.org/e
n/news/center-news/2002/10/Klausner-senior-advisor.html). Fred Hutch. 17 October 2002.
Retrieved 6 May 2019.
10. "Richard Klausner, MD, Senior VP and CMO, Illumina" (https://rosenmaninstitute.org/2015-s
peakers/2016/2/4/zvxaehjuunz1bjfrae1vy5px0scmyt). Rosenman Institute. Retrieved 6 May
2019.
11. "Dr Richard Klausner – IARC" (https://www.iarc.fr/friends-of-iarc/dr-richard-klausner/).
www.iarc.fr. Retrieved 6 May 2019.
12. "Richard D. Klausner, MD" (https://www.aacr.org/Membership/Pages/FellowDetailsNoModal.
aspx?ItemID=188). www.aacr.org. Retrieved 6 May 2019.
13. "Illumina Taps Phil Febbo to Oversee Precision Medicine Strategy as CMO" (https://www.cli
nicalomics.com/topics/precision-medicine-topic/companies/illumina-taps-phil-febbo-to-overs
ee-precision-medicine-strategy-as-cmo/). Clinical OMICs - Molecular Diagnostics in
Personalized Medicine. 13 March 2018. Retrieved 6 May 2019.
14. "Rick Klausner, Founder, Chief Scientist and Board Co-Chairman" (https://altoslabs.com/tea
m/leadership/rick-klausner/). altoslabs.com. Retrieved 15 Jan 2024.
15. "Richard Klausner, M.D. – LifeMine" (https://lifeminetx.com/rick-klausner-m-d/).
lifeminetx.com. 6 June 2017. Retrieved 6 May 2019.
16. "The American Society for Clinical Investigation" (https://www.the-asci.org/controllers/asci/A
sciProfileController.php?pid=159466). Retrieved 6 May 2019.
17. "Richard Klausner" (http://www.nasonline.org/member-directory/members/64199.html).
www.nasonline.org. Retrieved 6 May 2019.
External links
NCI in the Post-Klausner Era (https://theoncologist.alphamedpress.org/content/6/6/484.full)
Appearances (https://www.c-span.org/person/?41145) on C-SPAN
Retrieved from "https://en.wikipedia.org/w/index.php?title=Richard_Klausner&oldid=1217575187"
